Seòmar agus comataidhean

The Scottish Government is grateful to all Dispensing Appliance Contractors and community pharmacies for the service offered to stoma patients across Scotland and is committed to putting in place arrangements to best support them. Data shows that the volume of items provided by stoma suppliers has steadily increased by over two thirds (72.5%) since 2011 and suppliers are reimbursed for all items dispensed, resulting in a £2.539m increase (48%). Suppliers also benefit from a Global Sum of £3.8 million. Nevertheless, the Scottish Government recognises the requirement to keep arrangements under review and will explore whether changes are required to the fee structure and are within the affordability of the wider public sector finances.

1.New commercial arrangements were introduced in 2011 for the supply of stoma appliances to patients in the community and have been in place since. These arrangements are set up through contractual arrangements put in place by NHS Scotland National Procurement acting on behalf of Health Boards. They provide a framework which controls the cost of dispensing these items which is carried out by both Dispensing Appliance Contractors (DACs) and community pharmacy contractors who sign up to offer the service.

2.The arrangements are made up of a Global Sum for stoma appliance supply remuneration and fees for customisation and delivery. Suppliers are able to make profit on the sales and customisation aspects of the service. The Scottish Government’s Pharmacy Policy team holds meetings with the British Healthcare Trades Association (BHTA) who represent DACs in the UK. They have called for improvements to the current arrangements and discussions are currently being arranged to hear details of these proposals.

The Scottish Government does not hold this information.

Public Health Scotland publishes a yearly report named the ‘Prescription Cost Analysis’ which outlines annual total expenditure on all prescriptions from community pharmacy in Scotland. British National Formulary chapter 4 includes methadone and buprenorphine (also known by its brand name Buvidal) and the cost of prescribing these drugs can be found on tab 4 of the PCA at Dispenser payments and prescription cost analysis - Financial year 2023 to 2024 - Dispenser payments and prescription cost analysis - Publications - Public Health Scotland.

The Scottish Government’s Cardiovascular Disease (CVD) Risk Factors programme aims to reduce avoidable CVD death by 20% in 20 years. The focus is on improving the identification and management of key risk factors which are; high blood pressure, high cholesterol, raised blood sugars, obesity and smoking.

A key principle of the programme is to extend cardiovascular disease prevention efforts to those we know are at highest risk and particularly underserved by existing models of care.

We have also established a new GP enhanced service from the 2025-26 Reform Fund to support 100,000 patients who are at risk of developing CVD.

The Scottish Government values the input of clinicians in informing any recommendations regarding abortion services. The Scottish Government works closely with services through the Scottish Abortion Care Providers network in particular to identify contributors with suitable clinical backgrounds to be involved in any groups convened by the Scottish Government regarding abortion services.

No one should remain in hospital when they no longer need to be there, and we are clear that the current level of delay is unacceptable. It is important to reflect that 97% of all hospital discharges happen without delay. The latest published statistics show that the level of delayed discharges has fallen. At the end of April 2025, 1,868 people were delayed in hospital, 162 fewer than the high point of 2,030 delays at the end of October 2024.

In the 12 months to April 2025, there were 261,980 operations performed, 1.6% increase from the previous 12 months. Out of all the planned operations, only a small proportion were cancelled due to capacity reasons.

Addressing the variation in delays across the country is the focus of significant and sustained attention and effort by this Government. The NHS Scotland Operational Improvement Plan sets out a clear plan to reduce waiting times and delayed discharges, supported by £200 million targeted investment as part of the 2025-26 Budget.

The Scottish Government does not hold this information.

Public Health Scotland publishes a yearly report named the ‘Prescription Cost Analysis’ which outlines annual total expenditure on all prescriptions from community pharmacy in Scotland. British National Formulary chapter 4 includes methadone and buprenorphine (also known by its brand name Buvidal) and the cost of prescribing these drugs can be found on tab 4 of the PCA at Dispenser payments and prescription cost analysis - Financial year 2023 to 2024 - Dispenser payments and prescription cost analysis - Publications - Public Health Scotland.

Since the publication of the Stroke Improvement Plan, each NHS Board now has a named individual with responsibility for stroke care. The Minister for Public Health and Women’s Health chaired a roundtable meeting with these individuals in October 2024, outlining the Scottish Government’s priorities and expectations regarding stroke care.

A National Stroke Engagement Forum, which met for the first time on 2 October 2024, has been established. This forum, attended by stroke service representatives from every NHS Board, is helping to drive improvement work and facilitate the sharing of best practice across NHS Board boundaries.

An increased focus on rehabilitation is a key component of our Stroke Improvement Plan. We are now asking stroke services in all NHS Boards to offer a formal review to everyone who has had a stroke, taking place six months after the stroke event and allowing re-referral into stroke services where required. In addition, empirical measures of rehabilitation and stroke-specific Patient Reported Experience Measures (PREMS) are being developed and these will further enhance our ability to gauge the delivery of stroke care and rehabilitation.

Since the publication of the Stroke Improvement Plan, NHS Boards are now required to demonstrate adequate provision of psychological support for those who have suffered a stroke, and this is assessed via NHS Board reviews.

In terms of stroke prevention, the Scottish Government has launched the Cardiovascular Disease (CVD) Risk Factors programme to improve CVD outcomes with an aim to reduce avoidable CVD death by 20% in 20 years. This work focuses on improving the identification and management of key risk factors which are high blood pressure, high cholesterol, raised blood sugars, obesity and smoking. We have also established a new GP enhanced service from the 2025-26 Reform Fund to support 100,000 patients who are at risk of developing CVD.

Over the last ten years the Consultant Radiologist workforce has increased by 27.7% (from 304.5 WTE as at March 2015 to 388.9 WTE as at March 2025). Consultant Radiologist vacancies have decreased by 3.4% over the last year to 22.4 WTE as at March 2025, which is a vacancy rate of 5.5%.

The Scottish Government continues to invest heavily in radiology training. We are currently funding around 190 specialty training places in clinical radiology, including 78 extra places which have been added since 2014, based on modelling and future workforce need. This enables doctors to train and enter the workforce following completion of training - which takes a minimum of 5 years. Clinical radiology specialty training programmes have been filled at 100% in Scotland from 2014 to 2024, with 230 resident doctors successfully completing this training in this period.

The Scottish Government does not hold this information.